MB "Inovacinis rytojus" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 91,644 |
| - |
| 4,061 |
| 3,844 |
| - |
| 4.53 |
| 4.19 |
| 2,429 |
| 8,775 |
| 13,204 |
| 6,785 |
| 2023 |
|---|
| 178,504 |
| 99,723 |
| 56,049 |
| 53,206 |
| 29,724 |
| 98.58 |
| 29.81 |
| 42,951 |
| 10,739 |
| 9,029 |
| 51,657 |
| 2024 |
|---|
| 33,129 |
| 33,129 |
| -1,076 |
| -1,160 |
| -1,160 |
| 100.00 |
| -3.50 |
| 21,959 |
| 21,714 |
| 938 |
| 42,735 |
Register and
explore Okredo data| 2024 |
|---|
| 33,129 |
| 33,129 |
| -1,076 |
| -1,160 |
| -1,160 |
| 100.00 |
| -3.50 |
| 21,959 |
| 21,714 |
| 938 |
| 42,735 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
33,129 €-81 % *
Sales per employee (€)
33,129 €-67 % *
Profit before tax (€)
-1,076 €-102 % *
Net Profit (€)
-1,160 €-102 % *
Profit per employee (€)
-1,160 €-104 % *
Total profitability (%)
100.00 %1.44 % *
Net profitability (%)
-3.50 %-111.74 % *
Equity (€)
21,959 €-49 % *
Amounts Payable And Liabilities (€)
21,714 €102 % *
Non-current Assets (€)
938 €-90 % *
CurrentAssets (€)
42,735 €-17 % *
